SANUWAVE Health, Inc. (SNWV) Form 8-K — May 12, 2026
Sanuwave Health, Inc. reported Q1 2026 revenues of $9.6 million, a 3.1% increase from $9.3 million in Q1 2025. This marks the highest Q1 quarterly revenues in the company's history. The company's gross margin for Q1 2026 was 77.3%, down from 79.0% in Q1 2025, primarily due to lower pricing on Ultramist® systems and applicators.
Key figures
- Eps Beat
- 0
- Revenue
- 9619
- Guidance
- Q2 2026 revenue of $11.1 to $11.6 million (10-15% increase from Q2 2025); full year 2026 revenue guidance of $51.0-55.0 million (16-25% increase as compared to full year 2025 revenue).
- Total Debt
- 14330
- Revenue Yoy
- 3.1
- Cash Position
- 10779
- Shares Outstanding
- 8594209
Price after filing
1 day: +18.1%7 days: +4.1%30 days: -10.3%
Close on the filing date to close N calendar days later (from $16.04). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.